Professor Brenda Gannon joined the Centre for Business and Economics of Health, at The University of Queensland in 2016, as Mater Research Institute Chair in Health Economics.
Brenda is an international expert in the field of health and ageing economics and health econometrics and has won over $20 million in collaborative research income with economics, medicine and social science with academic and industry. Her research carries a dual role, (1) as a methodologist (applied health economist and econometrician using big and complex data), utilising health economics theory and concepts to test the validity of causal hypotheses, (2) collaborator across all Faculties leading critical economic evaluations.
Brenda’s methodological econometrics work is currently funded by Australian Research Council Discovery Grant. She is the lead economist on two major new Randomised Control Trials in dementia and emergency care, funded by EU H2020 and Health Research Board Ireland, Feasibility Trials in falls funded by EU H2020, phase 1 trial research in diabetes and evidence synthesis in stroke funded by NIHR HS&DR. All studies incorporate methodological innovations and applied research.
Previously she was an associate professor at The University of Manchester and University of Leeds from 2011-2016. Prior to that she was a senior research officer and deputy director at the Irish Centre for Social Geronotology/Department of Economics at the National University of Ireland, Galway and researcher at the Economic and Social Research Institute, Dublin, Ireland, under the Health Research Ireland, Health Economics and Inequalities programme of research.
Brenda is currently an Expert Evaluator for the EU Commission funding applications and recently a member of the NIHR RfPB (Research for Patient Benefit) Advisory Committee.